603456 Stock Overview
Manufactures and sells active pharmaceutical ingredients (API) and intermediates in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥14.27 |
| 52 Week High | CN¥24.28 |
| 52 Week Low | CN¥11.83 |
| Beta | 0.22 |
| 1 Month Change | -3.25% |
| 3 Month Change | -10.31% |
| 1 Year Change | -41.06% |
| 3 Year Change | -74.64% |
| 5 Year Change | -2.86% |
| Change since IPO | 131.20% |
Recent News & Updates
Zhejiang Jiuzhou Pharmaceutical Co., Ltd's (SHSE:603456) Shares Leap 25% Yet They're Still Not Telling The Full Story
Oct 01
Zhejiang Jiuzhou Pharmaceutical (SHSE:603456) Seems To Use Debt Quite Sensibly
Sep 25Recent updates
Zhejiang Jiuzhou Pharmaceutical Co., Ltd's (SHSE:603456) Shares Leap 25% Yet They're Still Not Telling The Full Story
Oct 01Zhejiang Jiuzhou Pharmaceutical (SHSE:603456) Seems To Use Debt Quite Sensibly
Sep 25Here's Why Zhejiang Jiuzhou Pharmaceutical (SHSE:603456) Can Manage Its Debt Responsibly
Jun 13Zhejiang Jiuzhou Pharmaceutical Co., Ltd's (SHSE:603456) Business And Shares Still Trailing The Market
May 24Zhejiang Jiuzhou Pharmaceutical's (SHSE:603456) Solid Earnings May Rest On Weak Foundations
May 01Zhejiang Jiuzhou Pharmaceutical Co., Ltd Just Missed Revenue By 17%: Here's What Analysts Think Will Happen Next
Apr 11Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHSE:603456) Shares Could Be 32% Above Their Intrinsic Value Estimate
Feb 28Shareholder Returns
| 603456 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 1.3% | -0.08% | 1.0% |
| 1Y | -41.1% | -6.0% | 8.2% |
Return vs Industry: 603456 underperformed the CN Pharmaceuticals industry which returned -5.7% over the past year.
Return vs Market: 603456 underperformed the CN Market which returned 8.3% over the past year.
Price Volatility
| 603456 volatility | |
|---|---|
| 603456 Average Weekly Movement | 6.1% |
| Pharmaceuticals Industry Average Movement | 6.7% |
| Market Average Movement | 8.1% |
| 10% most volatile stocks in CN Market | 12.2% |
| 10% least volatile stocks in CN Market | 5.1% |
Stable Share Price: 603456 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603456's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1973 | 4,877 | Yi Jiang Mei | www.jiuzhoupharma.com |
Zhejiang Jiuzhou Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients (API) and intermediates in China and internationally. Its API pipeline comprise central nervous system, non-steroidal, anti-infection, hypoglycemic and antiviral, tumor treatment, anti-depressant, Parkinson, HCV drugs, diabetes, cardiovascular, and respiratory anti-infection drugs. The company also provides asymmetric catalysts and lithium battery materials.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Fundamentals Summary
| 603456 fundamental statistics | |
|---|---|
| Market cap | CN¥12.78b |
| Earnings (TTM) | CN¥697.36m |
| Revenue (TTM) | CN¥4.91b |
18.3x
P/E Ratio2.6x
P/S RatioIs 603456 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603456 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.91b |
| Cost of Revenue | CN¥3.33b |
| Gross Profit | CN¥1.58b |
| Other Expenses | CN¥880.59m |
| Earnings | CN¥697.36m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Apr 11, 2025
| Earnings per share (EPS) | 0.78 |
| Gross Margin | 32.12% |
| Net Profit Margin | 14.20% |
| Debt/Equity Ratio | 5.7% |
How did 603456 perform over the long term?
See historical performance and comparisonDividends
3.5%
Current Dividend Yield65%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 04:40 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Zhejiang Jiuzhou Pharmaceutical Co., Ltd is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pei Cheng | China Galaxy Securities Co., Ltd. |
| Xiyuan Liu | China International Capital Corporation Limited |
| Wanhua Wu | China International Capital Corporation Limited |